Todd Cozzens
Co-Founder & Managing Partner @ Transformation Capital
Boston, United States
Todd Cozzens is a Series B investor at Transformation Capital in Boston focused on Health Care and Medical. Todd Cozzens is the Co-Founder & Managing Partner at Transformation Capital.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 71%
Last updated:
For AI agents: llms.txt
Industries Todd Cozzens invests in
Stages Todd Cozzens invests in
Countries Todd Cozzens invests in
Investment Focus
Industry
- Health Care 9 (64%)
- Medical 3 (21%)
- Hospital 3 (21%)
- Artificial Intelligence 3 (21%)
- mHealth 2 (14%)
Stage
- Series B 6 (43%)
- Series C 3 (21%)
- Series D 2 (14%)
- Series A 1 (7%)
- Funding Round 1 (7%)
Country
- United States 8 (57%)
- New Zealand 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Alaffia Health
|
Alaffia Health offers artificial intelligence solutions that support health plan claims operations by automating and improving clinical review workflows. Its platform uses AI agents to analyze complex medical claims data, extract structured clinical facts, and assist with payment integrity, utilization management, and appeals processing. Thecompany’s tools integrate with existing claims systems to prioritize cases, support clinician review, and help identify errors, waste, and inconsistencies before payment. Alaffia Health combines machine learning with clinician oversight to enhance accuracy in claims decisions and streamline administrative tasks for health insurance payers and related organizations. | $55M / Series B / Feb 03, 2026 | |
SmarterDx
|
SmarterDx is a clinical AI company that develops automated pre-bill review technology to assist hospitals in analyzing patient discharges. Its platform assists hospitals in analyzing patient discharges to identify missing diagnoses and improve documentation accuracy before billing. This approach helps hospitals recover lost revenue, improve qualitymetrics, and streamline the appeals process for denied claims. | $50M / Series B / May 14, 2024 | |
CodaMetrix
|
CodaMetrix is a tech company solving some of the more challenging problems in healthcare administrative and clinical areas. | $40M / Series B / Mar 12, 2024 | |
DexCare
|
DexCare is a provider of platform-as-a-service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform them into a highly scalable digital experience for their patients— increasing revenue from new,digital-first patients while minimizing new patient acquisition costs.DexCare was founded in 2021 and is headquartered in Seattle, WA. | $75M / Series C / Jun 21, 2023 | |
Vital
|
Keep patients more informed and engaged in the emergency room, hospital, and beyond. Vital’s AI-powered patient experience solutions give patients control, clarity, and predictability when they need it most. | $24.7M / Series B / Mar 23, 2023 | |
Memora Health
|
Memora Health, the leading intelligent care enablement platform, helps clinicians focus on top-of-license practice while proactively engaging patients along complex care journeys. Memora partners with leading health systems, health plans, and digital health companies to transform the care delivery process for care teams and patients. Our platformdigitizes and automates high-touch clinical workflows, supercharging care teams by intelligently triaging patient-reported concerns and data to appropriate care team members and providing patients with proactive, two-way communication and support. Memora Health is headquartered in San Francisco, CA, with clients and team members around the country, and is backed by Andreessen Horowitz, Transformation Capital, General Catalyst, AlleyCorp, Frist Cressey Ventures, Martin Ventures, Kevin Durant and Rich Kleiman's Thirty Five Ventures, and several other strategic healthcare groups.To learn more about Memora’s vision to make care more actionable, accessible and always-on, visit memorahealth.com. | $40M / Venture - Series Unknown / Feb 15, 2022 | |
|
DexCare
|
DexCare is a provider of platform-as-a-service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform them into a highly scalable digital experience for their patients— increasing revenue from new,digital-first patients while minimizing new patient acquisition costs.DexCare was founded in 2021 and is headquartered in Seattle, WA. | $50M / Series B / Jan 13, 2022 | |
Sword Health
|
SWORD Health is a digital musculoskeletal (MSK) therapy provider. The company pairs licensed physical therapists with innovative technology to help people overcome their chronic and post-surgical pain faster and more cost-effectively. We’re on a mission to free two billion people from pain by making it simple for people to recover at home, withoutresorting to imaging, surgeries, or opioids. Since launching in 2015, SWORD Health has worked with insurers, health systems, and employers in Europe, Australia, and the U.S. to give thousands of people access to preventative, chronic, and post-surgical MSK care that gets results. SWORD Health has offices in New York City, Chicago, Salt Lake City, Sydney, and Porto. | $163M / Series D / Nov 22, 2021 | |
|
Vital
|
Keep patients more informed and engaged in the emergency room, hospital, and beyond. Vital’s AI-powered patient experience solutions give patients control, clarity, and predictability when they need it most. | $15M / Series A / Sep 29, 2021 | |
|
Sword Health
|
SWORD Health is a digital musculoskeletal (MSK) therapy provider. The company pairs licensed physical therapists with innovative technology to help people overcome their chronic and post-surgical pain faster and more cost-effectively. We’re on a mission to free two billion people from pain by making it simple for people to recover at home, withoutresorting to imaging, surgeries, or opioids. Since launching in 2015, SWORD Health has worked with insurers, health systems, and employers in Europe, Australia, and the U.S. to give thousands of people access to preventative, chronic, and post-surgical MSK care that gets results. SWORD Health has offices in New York City, Chicago, Salt Lake City, Sydney, and Porto. | $85M / Series C / Jun 30, 2021 | |
| See all 14 investments → | |||
Co-Investors
About Transformation Capital
Transformation Capital is the successor management company to Leerink Transformation Partners LLC (“LTP”).11 LTP was founded in 2016 by Todd Cozzens and Jared Kesselheim, MD together with SVB Leerink Capital LLC (formerly Leerink Capital Partners LLC) (“Leerink Capital”), an affiliate of SVB Leerink LLC (“Leerink”), a leading healthcare investmentbank. Leerink Capital provided seed capital to Fund I (approximately 3% of capital commitments) and operational support. In January 2019, SVB Financial Group (“SVB”), the holding company of Silicon Valley Bank, a U.S.-based high-tech commercial bank, acquired the Leerink businesses including Leerink Capital. Todd Cozzens, Jared Kesselheim, MD, and SVB expect to agree to a mutually beneficial ongoing relationship in which Transformation Capital (as an independent management company owned by Todd Cozzens, Jared Kesselheim, MD, and Michael Dixon and not affiliated with SVB or Leerink Capital) shall manage Fund II and whereby Transformation Capital shall manage Fund I’s investment portfolio pursuant to a sub-advisory agreement with SVB (or an affiliate). Transformation Capital has the same operational leader, Kevin Brown, formerly CFO of Leerink Capital, and Transformation Capital expects to continue to derive benefits from its ongoing relationship with Leerink and SVB.
Transformation Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jared Kesselheim
Co-Founder & Managing Partner
|
|||
Jenna Ciotti
Vice President
|
|||
Julie Murchinson
Partner
|
|||
Michael Dixon
Managing Partner
|
|||
|
Todd Cozzens
Co-Founder & Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Todd Cozzens invest in?
Todd Cozzens invests primarily in Health Care, Medical and Hospital startups, most often at Series B and Series C stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Todd Cozzens last invest?
The most recent investment recorded for Todd Cozzens closed in Feb 2026. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
